Vu Truong, CEO at Aridis Pharmaceuticals, Inc. (ARDS), bought 5,000 shares at $5.11 ($26K) on 2021-07-27, disclosed to the SEC on 2021-07-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.